Should second doses be delayed? Should most adults receive half-doses? Scientists are pondering ways to get more shots into more arms.
Source: New York Times
As Rollout Falters, Scientists Debate New Vaccination Tactics
More from AstraZeneca PLCMore posts in AstraZeneca PLC »
- J.&J. Vaccine May Be Less Effective Against Delta, Study Suggests
- Citing the Delta Variant, Pfizer Will Pursue Booster Shots and a New Vaccine
- Three Studies, One Result: Vaccines Point the Way Out of the Pandemic
- Vaccines Are Effective Against the New York Variant, Studies Find
- The Pfizer-BioNTech Vaccine Is Said to Be Powerfully Protective in Adolescents
More from Clinical TrialsMore posts in Clinical Trials »
- Why a Century-Old Vaccine Offers New Hope Against Pathogens
- Why Monkeypox Vaccine Shortage May Threaten the Immunocompromised
- Vaccines for Young Children Are Coming, but Many Parents Have Tough Questions
- A Better Way to Measure Immunity in Children
- New Drug Slashed Deaths Among Patients With Severe Covid, Maker Claims
More from Coronavirus (2019-nCoV)More posts in Coronavirus (2019-nCoV) »
More from Food and Drug AdministrationMore posts in Food and Drug Administration »
- Breast Implants May Be Linked to Additional Cancers, F.D.A. Warns
- How the U.S. Let 20 Million Monkeypox Vaccine Doses Expire
- U.S. to Distribute 800,000 Doses of Monkeypox Vaccine
- As Monkeypox Spread in New York, 300,000 Vaccine Doses Sat in Denmark
- Demand for Monkeypox Vaccine Exceeds Supply, C.D.C. Says
More from Great BritainMore posts in Great Britain »
- In the Lives of the Tudors, Hints of the Present-Day Monarchy
- Prince Andrew Settles Sexual Abuse Lawsuit With Virginia Giuffre
- Woman Suing Prince Andrew for Abuse Settled With Epstein for $500,000
- Woman Suing Prince Andrew for Abuse Settled With Jeffrey Epstein for $500,000
- 17 New York Arts Organizations Are Among Those Receiving $30 Million
More from Immune SystemMore posts in Immune System »
- Will Covid Boosters Prevent Another Wave? Scientists Aren’t So Sure.
- Most Hospitalized Monkeypox Patients in the U.S. Were H.I.V.-Positive
- Why a Century-Old Vaccine Offers New Hope Against Pathogens
- Why Monkeypox Vaccine Shortage May Threaten the Immunocompromised
- A Better Way to Measure Immunity in Children
More from Pfizer IncMore posts in Pfizer Inc »
- Will Covid Boosters Prevent Another Wave? Scientists Aren’t So Sure.
- Scientists Are Gaining On RSV, a Persistent Threat to Children
- N.Y.C. to Offer Paxlovid at Mobile Virus Test Sites, First in U.S.
- Vaccines for Young Children Are Coming, but Many Parents Have Tough Questions
- A Better Way to Measure Immunity in Children
More from Public-Private Sector CooperationMore posts in Public-Private Sector Cooperation »
More from United StatesMore posts in United States »
- New Covid Booster Shots Cut Risk of Hospitalization by Half, CDC Reports
- Long Covid Has Played Role in More Than 3,500 Deaths in US, CDC Says
- Hometown of Tyler Adams, U.S. Captain, Still Proud Even With Loss
- Judge Criticizes D.A. for Halting Prosecution of Woman in Husband’s Death
- New York Philharmonic Was Once All-Male. Now, Women Outnumber Men.
More from Vaccination and ImmunizationMore posts in Vaccination and Immunization »
- New Covid Booster Shots Cut Risk of Hospitalization by Half, CDC Reports
- Will Covid Boosters Prevent Another Wave? Scientists Aren’t So Sure.
- Why It Was Easier to Curb Monkeypox Than Covid
- NYC Ends Monkeypox Emergency and Mobile Vaccine Vans
- Scientists Are Gaining On RSV, a Persistent Threat to Children
Be First to Comment